ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,977Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 761

$850K Total Retail Price of All Prescriptions

Rank: 22 out of 761

780 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 780 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 780 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 16,713 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 863 823 1 3
SIMVASTATIN 819 768 2 2
LISINOPRIL 751 687 3 1
OMEPRAZOLE 640 579 4 4
WARFARIN SODIUM 564 535 5 9
AMLODIPINE BESYLATE 539 519 6 6
FUROSEMIDE 503 468 7 7
ATORVASTATIN CALCIUM 468 418 8 12
HYDROCODONE-ACETAMINOPHEN 445 364 S3 9 5
ATENOLOL 433 412 10 8
METOPROLOL TARTRATE 381 352 11 14
POTASSIUM CHLORIDE 325 304 12 18
CITALOPRAM HBR 304 289 13 19
ZOLPIDEM TARTRATE 269 199 14 22
LOSARTAN POTASSIUM 267 253 15 13
GABAPENTIN 261 212 16 15
METOPROLOL SUCCINATE 251 237 17 16
METFORMIN HCL 240 213 18 10
LOVASTATIN 237 226 19 17
HYDROCHLOROTHIAZIDE 218 181 20 11
GLIMEPIRIDE 211 185 21 48
DONEPEZIL HCL 210 210 22 33
TRAZODONE HCL 208 192 23 23
ALENDRONATE SODIUM 197 189 24 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 180 25 35
TAMSULOSIN HCL 195 184 25 27
FENTANYL 195 156 S2 25 57
MORPHINE SULFATE ER 182 93 S2 28 38
CARVEDILOL 173 147 29 26
PRAVASTATIN SODIUM 173 154 29 20
CRESTOR 155 139 31 36
ALLOPURINOL 131 119 32 28
FLUOXETINE HCL 130 89 33 31
ISOSORBIDE MONONITRATE ER 129 120 34 72
CIPROFLOXACIN HCL 125 115 35 63
OXYCODONE-ACETAMINOPHEN 119 76 S2 36 49
DIGOXIN 119 103 36 43
TRIAMTERENE-HCTZ 112 110 38 42
DOXAZOSIN MESYLATE 111 94 39 55
SULINDAC 108 108 40 271
TRIAMCINOLONE ACETONIDE 108 98 40 84
OXYCODONE HCL 105 87 S2 42 24
SERTRALINE HCL 104 91 43 25
CYCLOBENZAPRINE HCL 104 78 R 43 51
PREDNISONE 103 79 45 30
NAMENDA 103 103 45 59
LANTUS 102 102 47 41
MIRTAZAPINE 101 82 48 50
FINASTERIDE 98 98 49 73
KLOR-CON 10 96 96 50 74
FLUTICASONE PROPIONATE 94 82 51 29
POLYETHYLENE GLYCOL 3350 93 73 52 62
SPIRIVA 90 64 53 56
ADVAIR DISKUS 90 78 53 37
VENLAFAXINE HCL ER 83 72 55 76
AZITHROMYCIN 82 75 56 70
GLIPIZIDE 81 81 57 39
MELOXICAM 80 68 58 61
NORTRIPTYLINE HCL 78 67 59 101
CLONIDINE HCL 76 66 60 69
CARBIDOPA-LEVODOPA 76 71 60 82
AGGRENOX 75 75 62 121
TRAMADOL HCL 75 34 62 34
COMBIVENT 75 75 62 110
HYDRALAZINE HCL 68 68 65 114
HUMALOG 66 66 66 123
RISPERIDONE 65 59 67 83
DETROL LA 62 56 68 196
PAROXETINE HCL 62 59 68 47
RANITIDINE HCL 61 50 70 52
METHADONE HCL 59 31 S2 71 75
SULFAMETHOXAZOLE-TRIMETHOPRIM 59 46 71 117
DILTIAZEM ER 59 59 71 130
SPIRONOLACTONE 57 36 74 45
TRICOR 56 56 75 164
FAMOTIDINE 53 51 76 60
NABUMETONE 52 51 77 133
CEPHALEXIN 50 46 78 145
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.